The impact of the benefit ratio on ACER of different screening strategies based on the results of sensitivity analysis.

Erin M. Stuckey (625700)
Jennifer Stevenson (640762)
Katya Galactionova (640763)
Amrish Y. Baidjoe (640764)
Teun Bousema (79969)
Wycliffe Odongo (470912)
Simon Kariuki (250853)
Chris Drakeley (79962)
Thomas A. Smith (95630)
Jonathan Cox (207677)
Nakul Chitnis (187823)

October 2014

Tornado diagram of the change in the ACER of an intervention with 80% LLIN use, 90% IRS coverage,...

A univariable sensitivity analysis of the ICER for different parameters over the range for each parameter (ICER, incremental cost-effectiveness ratio).

Amir Shlomai (5629004)
Moshe Leshno (3154716)
Daniel A. Goldstein (5946596)

November 2018

A univariable sensitivity analysis of the ICER for different parameters over the range for each para...

Probabilistic sensitivity analysis of cost-effectiveness analysis for the screening program for age-related macular degeneration.

Hiroshi Tamura (371719)
Rei Goto (478222)
Yoko Akune (775757)
Yoshimune Hiratsuka (457603)
Shusuke Hiragi (775758)
Masakazu Yamada (248678)

July 2015

Probabilistic sensitivity analysis of cost-effectiveness analysis for the screening program for a...

The impact of the benefit ratio on ICER of shifting strategies based on the results of sensitivity analysis.

Ruoyan Gai Tobe (102986)
Rintaro Mori (102988)
Lihui Huang (102990)
Lingzhong Xu (102992)
Demin Han (102993)
Kenji Shibuya (102994)

January 2013

Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using OAE; Se...

Costs, health effects, and cost-effectiveness of different screening strategies.

Ruoyan Gai Tobe (102986)
Rintaro Mori (102988)
Lihui Huang (102990)
Lingzhong Xu (102992)
Demin Han (102993)
Kenji Shibuya (102994)

January 2013

Note: Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using O...

Results of one-way sensitivity analysis on key model parameters.

Gijs Hubben (353787)
Martin Bootsma (239407)
Michiel Luteijn (353788)
Diarmuid Glynn (353790)
David Bishai (353792)
Marc Bonten (228738)
Maarten Postma (353794)

February 2013

Parameters are ranked by the magnitude of their impact on the average ...

Univariate sensitivity analyses: effects of varying base-case estimates on the incremental cost-effectiveness ratio of treating all patients with ACE inhibitors vs screening for microalbuminuria (reference strategy).

Charles Christian Adarkwah (342183)
Afschin Gandjour (342184)
Maren Akkerman (342185)
Silvia M. Evers (342186)

February 2013

QALYs = quality-adjusted life years; ACE = angiotensin-converting enzyme; ESRD = end-stage ...

Incremental cost-effectiveness ratio (ICER) of screening optimized to a pre-vaccination cohort as compared to screening optimized to a vaccinated cohort, for unvaccinated women who benefit from different herd immunity levels, under both base case assumptions and sensitivity analyses.

Steffie K. Naber (2175986)
Suzette M. Matthijsse (688353)
Kirsten Rozemeijer (2175982)
Corine Penning (2175984)
Inge M. C. M. de Kok (688354)
Marjolein van Ballegooijen (618131)

January 2016

Incremental cost-effectiveness ratio (ICER) of screening optimized to a pre-vaccination cohort as...

The cost in per Disability-Adjusted Life Years (DALYs) of four screening strategies compared with no screening.

Ruoyan Gai Tobe (102986)
Rintaro Mori (102988)
Lihui Huang (102990)
Lingzhong Xu (102992)
Demin Han (102993)
Kenji Shibuya (102994)

January 2013

Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using OAE; Se...

The results of the one-way sensitivity analysis.

Clémence Perraudin (424942)
Marc Le Vaillant (346037)
Nathalie Pelletier-Fleury (325738)

June 2013

Incremental Cost-Effectiveness ratios (ICER) are expressed in Euros per QALY gained (€/Q)....

One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.

Benjamin O. Yarnoff (3154848)
Thomas J. Hoerger (3154857)
Siobhan A. Simpson (3154860)
Meda E. Pavkov (3154854)
Nilka R. Burrows (3154863)
Sundar S. Shrestha (3143406)
Desmond E. Williams (2208379)
Xiaohui Zhuo (3154851)

July 2016

One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.</p

One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.

Brooke E. Nichols (390862)
Charles A. B. Boucher (306753)
Janneke H. van Dijk (277226)
Phil E. Thuma (390863)
Jan L. Nouwen (387450)
Rob Baltussen (213036)
Janneke van de Wijgert (36860)
Peter M. A. Sloot (132292)
David A. M. C. van de Vijver (363430)

March 2013

One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.</p

Mexico- Results of sensitivity analysis on average cost-effectiveness ratio (ACER).

Laurens M. Niëns (242759)
Sten G. Zelle (495292)
Cristina Gutiérrez-Delgado (555730)
Gustavo Rivera Peña (555731)
Blanca Rosa Hidalgo Balarezo (555732)
Erick Rodriguez Steller (555733)
Frans F. H. Rutten (555734)

April 2014

aUnidad de Análisis Económico - 8.4% stage I, 38.5% stage II, 42.5% stage III, 10.6% stage IV <a ...

One-way sensitivity analyses of the incremental cost-effectiveness ratio of using the partner notification system over 5 years in Scenario 1 in which 5% of patients are diagnosed via the online partner notification system.

Brooke E. Nichols (390862)
Hannelore M. Götz (392049)
Eric C. M. van Gorp (225896)
Annelies Verbon (175842)
Casper Rokx (824244)
Charles A. B. Boucher (306753)
David A. M. C. van de Vijver (363430)

November 2015

Each horizontal bar represents the full range of cost-effectiveness ratios produced by varying a ...

Impact of vaccine effectiveness and vaccination coverage (all persons 18+) on incremental cost effectiveness ratios (ICER).

Samuel K. Peasah (6645653)
Martin I. Meltzer (211579)
Michelle Vu (6645656)
Danielle L. Moulia (6645659)
Carolyn B. Bridges (211567)

April 2019

Impact of vaccine effectiveness and vaccination coverage (all persons 18+) on incremental cost effec...

Sensitivity analysis.

Erin M. Stuckey (625700)
Jennifer Stevenson (640762)
Katya Galactionova (640763)
Amrish Y. Baidjoe (640764)
Teun Bousema (79969)
Wycliffe Odongo (470912)
Simon Kariuki (250853)
Chris Drakeley (79962)
Thomas A. Smith (95630)
Jonathan Cox (207677)
Nakul Chitnis (187823)

October 2014

Tornado diagram of the change in the ACER of an intervention with 80% LLIN use, 90% IRS coverage,...

A univariable sensitivity analysis of the ICER for different parameters over the range for each parameter (ICER, incremental cost-effectiveness ratio).

Amir Shlomai (5629004)
Moshe Leshno (3154716)
Daniel A. Goldstein (5946596)

November 2018

A univariable sensitivity analysis of the ICER for different parameters over the range for each para...

Probabilistic sensitivity analysis of cost-effectiveness analysis for the screening program for age-related macular degeneration.

Hiroshi Tamura (371719)
Rei Goto (478222)
Yoko Akune (775757)
Yoshimune Hiratsuka (457603)
Shusuke Hiragi (775758)
Masakazu Yamada (248678)

July 2015

Probabilistic sensitivity analysis of cost-effectiveness analysis for the screening program for a...

The impact of the benefit ratio on ICER of shifting strategies based on the results of sensitivity analysis.

Ruoyan Gai Tobe (102986)
Rintaro Mori (102988)
Lihui Huang (102990)
Lingzhong Xu (102992)
Demin Han (102993)
Kenji Shibuya (102994)

January 2013

Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using OAE; Se...

Costs, health effects, and cost-effectiveness of different screening strategies.

Ruoyan Gai Tobe (102986)
Rintaro Mori (102988)
Lihui Huang (102990)
Lingzhong Xu (102992)
Demin Han (102993)
Kenji Shibuya (102994)

January 2013

Note: Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using O...

Results of one-way sensitivity analysis on key model parameters.

Gijs Hubben (353787)
Martin Bootsma (239407)
Michiel Luteijn (353788)
Diarmuid Glynn (353790)
David Bishai (353792)
Marc Bonten (228738)
Maarten Postma (353794)

February 2013

Parameters are ranked by the magnitude of their impact on the average ...

Univariate sensitivity analyses: effects of varying base-case estimates on the incremental cost-effectiveness ratio of treating all patients with ACE inhibitors vs screening for microalbuminuria (reference strategy).

Charles Christian Adarkwah (342183)
Afschin Gandjour (342184)
Maren Akkerman (342185)
Silvia M. Evers (342186)

February 2013

QALYs = quality-adjusted life years; ACE = angiotensin-converting enzyme; ESRD = end-stage ...

Incremental cost-effectiveness ratio (ICER) of screening optimized to a pre-vaccination cohort as compared to screening optimized to a vaccinated cohort, for unvaccinated women who benefit from different herd immunity levels, under both base case assumptions and sensitivity analyses.

Steffie K. Naber (2175986)
Suzette M. Matthijsse (688353)
Kirsten Rozemeijer (2175982)
Corine Penning (2175984)
Inge M. C. M. de Kok (688354)
Marjolein van Ballegooijen (618131)

January 2016

Incremental cost-effectiveness ratio (ICER) of screening optimized to a pre-vaccination cohort as...

The cost in per Disability-Adjusted Life Years (DALYs) of four screening strategies compared with no screening.

Ruoyan Gai Tobe (102986)
Rintaro Mori (102988)
Lihui Huang (102990)
Lingzhong Xu (102992)
Demin Han (102993)
Kenji Shibuya (102994)

January 2013

Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using OAE; Se...

The results of the one-way sensitivity analysis.

Clémence Perraudin (424942)
Marc Le Vaillant (346037)
Nathalie Pelletier-Fleury (325738)

June 2013

Incremental Cost-Effectiveness ratios (ICER) are expressed in Euros per QALY gained (€/Q)....

One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.

Benjamin O. Yarnoff (3154848)
Thomas J. Hoerger (3154857)
Siobhan A. Simpson (3154860)
Meda E. Pavkov (3154854)
Nilka R. Burrows (3154863)
Sundar S. Shrestha (3143406)
Desmond E. Williams (2208379)
Xiaohui Zhuo (3154851)

July 2016

One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.</p

One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.

Brooke E. Nichols (390862)
Charles A. B. Boucher (306753)
Janneke H. van Dijk (277226)
Phil E. Thuma (390863)
Jan L. Nouwen (387450)
Rob Baltussen (213036)
Janneke van de Wijgert (36860)
Peter M. A. Sloot (132292)
David A. M. C. van de Vijver (363430)

March 2013

One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.</p

Mexico- Results of sensitivity analysis on average cost-effectiveness ratio (ACER).

Laurens M. Niëns (242759)
Sten G. Zelle (495292)
Cristina Gutiérrez-Delgado (555730)
Gustavo Rivera Peña (555731)
Blanca Rosa Hidalgo Balarezo (555732)
Erick Rodriguez Steller (555733)
Frans F. H. Rutten (555734)

April 2014

aUnidad de Análisis Económico - 8.4% stage I, 38.5% stage II, 42.5% stage III, 10.6% stage IV <a ...

One-way sensitivity analyses of the incremental cost-effectiveness ratio of using the partner notification system over 5 years in Scenario 1 in which 5% of patients are diagnosed via the online partner notification system.

Brooke E. Nichols (390862)
Hannelore M. Götz (392049)
Eric C. M. van Gorp (225896)
Annelies Verbon (175842)
Casper Rokx (824244)
Charles A. B. Boucher (306753)
David A. M. C. van de Vijver (363430)

November 2015

Each horizontal bar represents the full range of cost-effectiveness ratios produced by varying a ...

Impact of vaccine effectiveness and vaccination coverage (all persons 18+) on incremental cost effectiveness ratios (ICER).

Samuel K. Peasah (6645653)
Martin I. Meltzer (211579)
Michelle Vu (6645656)
Danielle L. Moulia (6645659)
Carolyn B. Bridges (211567)

April 2019

Impact of vaccine effectiveness and vaccination coverage (all persons 18+) on incremental cost effec...

Sensitivity analysis.

Erin M. Stuckey (625700)
Jennifer Stevenson (640762)
Katya Galactionova (640763)
Amrish Y. Baidjoe (640764)
Teun Bousema (79969)
Wycliffe Odongo (470912)
Simon Kariuki (250853)
Chris Drakeley (79962)
Thomas A. Smith (95630)
Jonathan Cox (207677)
Nakul Chitnis (187823)

October 2014

Tornado diagram of the change in the ACER of an intervention with 80% LLIN use, 90% IRS coverage,...

A univariable sensitivity analysis of the ICER for different parameters over the range for each parameter (ICER, incremental cost-effectiveness ratio).

Amir Shlomai (5629004)
Moshe Leshno (3154716)
Daniel A. Goldstein (5946596)

November 2018

A univariable sensitivity analysis of the ICER for different parameters over the range for each para...

Probabilistic sensitivity analysis of cost-effectiveness analysis for the screening program for age-related macular degeneration.

Hiroshi Tamura (371719)
Rei Goto (478222)
Yoko Akune (775757)
Yoshimune Hiratsuka (457603)
Shusuke Hiragi (775758)
Masakazu Yamada (248678)

July 2015

Probabilistic sensitivity analysis of cost-effectiveness analysis for the screening program for a...

The impact of the benefit ratio on ACER of different screening strategies based on the results of sensitivity analysis.

Abstract

Extracted data

The impact of the benefit ratio on ACER of different screening strategies based on the results of sensitivity analysis.

Abstract

Extracted data

Related items

Related items